{"disease":{"id":"cellulitis","name":"cellulitis"},"drugs":{"marketed":[{"drug_id":"clindamycin-phosphate","indication_name":"Anaerobic Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleocin T","generic_name":"CLINDAMYCIN PHOSPHATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Lincosamide Antibacterial","quality_score":51,"revenue":null,"mechanism":"Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death."},{"drug_id":"cefotaxime","indication_name":"Bacteroides Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Claforan","generic_name":"CEFOTAXIME","company_name":"Sterimax","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"cefotaxime","indication_name":"Clostridium Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Claforan","generic_name":"CEFOTAXIME","company_name":"Sterimax","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"cefotaxime","indication_name":"E. Coli Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Claforan","generic_name":"CEFOTAXIME","company_name":"Sterimax","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"cefotaxime","indication_name":"Enterococcus Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Claforan","generic_name":"CEFOTAXIME","company_name":"Sterimax","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"clindamycin","indication_name":"Anaerobic Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleocin","generic_name":"clindamycin","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"50S ribosomal protein L10","drug_class":"Lincosamide antibiotic","quality_score":56,"revenue":null,"mechanism":"Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage."},{"drug_id":"piperacillin","indication_name":"Bacteroides Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pipracil","generic_name":"PIPERACILLIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"piperacillin","quality_score":10,"revenue":null,"mechanism":"Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death."},{"drug_id":"piperacillin","indication_name":"Enterococcus Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pipracil","generic_name":"PIPERACILLIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"piperacillin","quality_score":10,"revenue":null,"mechanism":"Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death."},{"drug_id":"piperacillin","indication_name":"Neisseria Gonorrhea Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pipracil","generic_name":"PIPERACILLIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"piperacillin","quality_score":10,"revenue":null,"mechanism":"Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death."},{"drug_id":"ceftazidime","indication_name":"E. Coli Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fortaz","generic_name":"CEFTAZIDIME","company_name":"Pai Holdings Pharm","drug_phase":"marketed","molecular_target":"","drug_class":"ceftazidime","quality_score":10,"revenue":null,"mechanism":"Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death."},{"drug_id":"cefoxitin","indication_name":"Bacteroides Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cefoxitin","indication_name":"Clostridium Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cefoxitin","indication_name":"E. Coli Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cefoxitin","indication_name":"Female pelvic cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cefoxitin","indication_name":"Neisseria Gonorrhea Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cefoxitin","indication_name":"Peptococcus Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cefoxitin","indication_name":"Peptostreptococcus Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mefoxin In Sodium Chloride 0.9% In Plastic Container","generic_name":"CEFOXITIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Cephalosporin Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"tazicef","indication_name":"E. Coli Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fortaz","generic_name":"Ceftazidime","company_name":"Pai Holdings Pharm","drug_phase":"marketed","molecular_target":"Bacterial cell wall","drug_class":"Third-generation cephalosporin","quality_score":10,"revenue":null,"mechanism":"Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance."},{"drug_id":"norfloxacin","indication_name":"Bacteroides Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"E. Coli Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"Enterococcus Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"Female pelvic cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"Gardnerella Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"Peptostreptococcus Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"Prevotella Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"Streptococcal Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ceftazidim","indication_name":"E. Coli Pelvic Cellulitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ceftazidim","company_name":"Tel-Aviv Sourasky Medical Center","drug_phase":"marketed","molecular_target":"Penicillin-binding protein 1A, Penicillin-binding protein 1B, Peptidoglycan synthase FtsI","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":27,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03781024","title":"A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Data Collection Analysis Business Management","has_results":false},{"nct_id":"NCT06715306","title":"Intravenous Versus Oral Treatment of the Main Acute Infections","phase":"NA","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT05473325","title":"Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Willows Health","has_results":false},{"nct_id":"NCT05226260","title":"Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":1634,"lead_sponsor_name":"Nationwide Children's Hospital","has_results":false},{"nct_id":"NCT06526884","title":"Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1080,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04393909","title":"Improving Safety of Diagnosis and Therapy in the Inpatient Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT02127970","title":"Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":698,"lead_sponsor_name":"Durata Therapeutics Inc., an affiliate of Allergan plc","has_results":true},{"nct_id":"NCT03917134","title":"Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"CES University","has_results":false},{"nct_id":"NCT04928235","title":"Utility of Thermal Imaging in Diagnosis of Cellulitis for Lower Extremity Complaints in the Emergency Department","phase":"","overall_status":"COMPLETED","enrollment_count":416,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT05584007","title":"Cellulitis Optimal Antibiotic Treatment","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":356,"lead_sponsor_name":"University of Southampton","has_results":false},{"nct_id":"NCT05023200","title":"The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study","phase":"","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"University of Sussex","has_results":true},{"nct_id":"NCT05959928","title":"Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using Viture","phase":"","overall_status":"COMPLETED","enrollment_count":208,"lead_sponsor_name":"Vitio Medical S.L.","has_results":false},{"nct_id":"NCT01519778","title":"A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT02032654","title":"Duration of ANtibiotic Therapy for CEllulitis","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":151,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT06358846","title":"Effectiveness of Educational Intervention on Footcare Among Individuals Having Type 2 Diabetes at Slums of Karachi, Pakistan.","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"SINA Health Education and Welfare Trust","has_results":false},{"nct_id":"NCT03296280","title":"Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program","phase":"","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT00295178","title":"Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":false},{"nct_id":"NCT07492030","title":"Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":74,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT03619746","title":"Point-of-Care Ultrasound Educational Initiative for Insect Bites","phase":"NA","overall_status":"TERMINATED","enrollment_count":71,"lead_sponsor_name":"New York City Health and Hospitals Corporation","has_results":false},{"nct_id":"NCT04471246","title":"High-dose vs. Standard-dose Cephalexin for Cellulitis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":true},{"nct_id":"NCT04091672","title":"RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Avita Medical","has_results":true},{"nct_id":"NCT03785834","title":"The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT03846635","title":"Handheld Infrared Thermometer to Evaluate Cellulitis","phase":"","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT06283056","title":"RF Microneedling With Multi-Depth Targeting Per Insertion for The Treatment of Cellulite","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"InMode MD Ltd.","has_results":false},{"nct_id":"NCT03474523","title":"Effectiveness of Diathermy-Radiofrecuency Compared With Cavitation in Cellulitis Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University of Cadiz","has_results":false},{"nct_id":"NCT03312946","title":"Effect of Vibro-oscillatory Therapy for Improvement of Body Contour and Appearance of Cellulite.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Indústria Brasileira Equipamentos Médicos - IBRAMED","has_results":false},{"nct_id":"NCT07345819","title":"Dexamethasone vs. Placebo in Children and Youth Hospitalized for Orbital Cellulitis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT03275259","title":"Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Indústria Brasileira Equipamentos Médicos - IBRAMED","has_results":false},{"nct_id":"NCT03199781","title":"Motorized Mechanical Massage Associated With Cosmetics in Improving Body Contour and Appearance of Gynoid Lipodystrophy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Indústria Brasileira Equipamentos Médicos - IBRAMED","has_results":false},{"nct_id":"NCT03556917","title":"The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Universidade Norte do Paraná","has_results":false},{"nct_id":"NCT05624216","title":"Radiofrequency and Targeted Pressure Energy for Cellulite Reduction","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"BTL Industries Ltd.","has_results":false},{"nct_id":"NCT06231940","title":"Efficacy of Complex Decongestive Therapy (CDT) in Patients With Venous Insufficiency: a Experimental Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"University of Salamanca","has_results":false},{"nct_id":"NCT04456556","title":"Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)","phase":"","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT04272814","title":"Compression Therapy for Acute Lower Limb Cellulitis","phase":"NA","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"University Hospital Plymouth NHS Trust","has_results":false},{"nct_id":"NCT00893048","title":"The Use of Oral Steroids in the Treatment of Cellulitis","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT01238276","title":"Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Sonescence, Inc.","has_results":false}],"total":36},"guidelines":[],"source":"Drug Landscape verified database"}